Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003933 · ClinicalTrials.gov registry record · NA
Diagnostic Study of Gene Alterations in Children Who Have Been Treated for Relapsed Acute Lymphocytic Leukemia
A NA study, sponsored by Children's Oncology Group.
- Completed
- Registry status
- NA
- Development phase
NCT00003933: Completed NA study, sponsored by Children's Oncology Group.
NCT00003933 is a NA study that has completed, run by Children's Oncology Group. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003933, a NA study, has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
RATIONALE: Diagnostic procedures, such as genetic testing, may improve the ability to detect acute lymphocytic leukemia and determine the extent of disease. PURPOSE: Diagnostic study to try to detect changes in the genes of children who have been treated for relapsed acute lymphocytic leukemia.
Interventions
- OTHER laboratory biomarker analysis
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-04 |
| Phase | NA |
What the finished NCT00003933 record still lists
NCT00003933 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which laboratory biomarker analysis is the first listed.
NCT00003933 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00003933 about?
NCT00003933 is a clinical study titled "Diagnostic Study of Gene Alterations in Children Who Have Been Treated for Relapsed Acute Lymphocytic Leukemia". RATIONALE: Diagnostic procedures, such as genetic testing, may improve the ability to detect acute lymphocytic leukemia and determine the extent of disease. PURPOSE: Diagnostic study to try to detect changes in the genes of children who have been treated for relapsed acute lymphocytic leukemia.
What is the current status of trial NCT00003933?
This trial is currently completed. It is a NA study. The study started on 1999-04.
What interventions are being tested in trial NCT00003933?
The interventions under investigation include: laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT00003933?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia